1146 related articles for article (PubMed ID: 29455082)
1. Evaluating subjective cognitive impairment in the adult epilepsy clinic: Effects of depression, number of antiepileptic medications, and seizure frequency.
Feldman L; Lapin B; Busch RM; Bautista JF
Epilepsy Behav; 2018 Apr; 81():18-24. PubMed ID: 29455082
[TBL] [Abstract][Full Text] [Related]
2. Cognitive impairment in adults with epilepsy: The relationship between subjective and objective assessments of cognition.
Samarasekera SR; Helmstaedter C; Reuber M
Epilepsy Behav; 2015 Nov; 52(Pt A):9-13. PubMed ID: 26398591
[TBL] [Abstract][Full Text] [Related]
3. Antiepileptic drug effects on subjective and objective cognition.
Quon RJ; Mazanec MT; Schmidt SS; Andrew AS; Roth RM; MacKenzie TA; Sajatovic M; Spruill T; Jobst BC
Epilepsy Behav; 2020 Mar; 104(Pt A):106906. PubMed ID: 32006792
[TBL] [Abstract][Full Text] [Related]
4. The A-B neuropsychological assessment schedule (ABNAS): the relationship between patient-perceived drug related cognitive impairment and results of neuropsychological tests.
Aldenkamp AP; van Meel HF; Baker GA; Brooks J; Hendriks MP
Seizure; 2002 Jun; 11(4):231-7. PubMed ID: 12027569
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy.
Fritz N; Glogau S; Hoffmann J; Rademacher M; Elger CE; Helmstaedter C
Epilepsy Behav; 2005 May; 6(3):373-81. PubMed ID: 15820346
[TBL] [Abstract][Full Text] [Related]
6. Epilepsy in patients with primary brain tumors: The impact on mood, cognition, and HRQOL.
Rahman Z; Wong CH; Dexter M; Olsson G; Wong M; Gebsky V; Nahar N; Wood A; Byth K; King M; Bleasel AB
Epilepsy Behav; 2015 Jul; 48():88-95. PubMed ID: 26136184
[TBL] [Abstract][Full Text] [Related]
7. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
Helmstaedter C; Witt JA
Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
[TBL] [Abstract][Full Text] [Related]
8. Migraine comorbidity and cognitive performance in patients with focal epilepsy.
Begasse de Dhaem OAJ; French J; Morrison C; Meador KJ; Hesdorffer DC; Cristofaro S; Minen MT;
Epilepsy Behav; 2019 Aug; 97():29-33. PubMed ID: 31181426
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of the impact of memory and mood on antiepileptic drug adherence.
McAuley JW; Passen N; Prusa C; Dixon J; Cotterman-Hart S; Shneker BF
Epilepsy Behav; 2015 Feb; 43():61-5. PubMed ID: 25561379
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients.
Petrovski S; Szoeke CE; Jones NC; Salzberg MR; Sheffield LJ; Huggins RM; O'Brien TJ
Neurology; 2010 Sep; 75(11):1015-21. PubMed ID: 20837970
[TBL] [Abstract][Full Text] [Related]
11. EpiTrack: tracking cognitive side effects of medication on attention and executive functions in patients with epilepsy.
Lutz MT; Helmstaedter C
Epilepsy Behav; 2005 Dec; 7(4):708-14. PubMed ID: 16266826
[TBL] [Abstract][Full Text] [Related]
12. The effects of adjunctive topiramate on cognitive function in patients with epilepsy.
Lee S; Sziklas V; Andermann F; Farnham S; Risse G; Gustafson M; Gates J; Penovich P; Al-Asmi A; Dubeau F; Jones-Gotman M
Epilepsia; 2003 Mar; 44(3):339-47. PubMed ID: 12614389
[TBL] [Abstract][Full Text] [Related]
13. The effect of phenobarbitone on cognition in adult patients with new onset epilepsy: a multi-centric prospective study from India.
Satischandra P; Rao SL; Ravat S; Jayalakhsmi S; Senapathy A; Shah U; Shunmukhi MS; Dutta A; Mukaddam Q; Naik M; Subbakrishna DK; Sinha S
Epilepsy Res; 2014 Jul; 108(5):928-36. PubMed ID: 24735753
[TBL] [Abstract][Full Text] [Related]
14. Cognitive adverse events of topiramate in patients with epilepsy and intellectual disability.
Brandt C; Lahr D; May TW
Epilepsy Behav; 2015 Apr; 45():261-4. PubMed ID: 25843340
[TBL] [Abstract][Full Text] [Related]
15. The A-B neuropsychological assessment schedule (ABNAS): the further refinement of a patient-based scale of patient-perceived cognitive functioning.
Brooks J; Baker GA; Aldenkamp AP
Epilepsy Res; 2001 Mar; 43(3):227-37. PubMed ID: 11248534
[TBL] [Abstract][Full Text] [Related]
16. Factors for cognitive impairment in adult epileptic patients.
Wang L; Chen S; Liu C; Lin W; Huang H
Brain Behav; 2020 Jan; 10(1):e01475. PubMed ID: 31863643
[TBL] [Abstract][Full Text] [Related]
17. Cognitive impairment in older adults with epilepsy: Characterization and risk factor analysis.
Miller LA; Galioto R; Tremont G; Davis J; Bryant K; Roth J; LaFrance WC; Blum AS
Epilepsy Behav; 2016 Mar; 56():113-7. PubMed ID: 26859320
[TBL] [Abstract][Full Text] [Related]
18. Effect of lacosamide on depression and anxiety symptoms in patients with focal refractory epilepsy: A prospective multicenter study.
Rocamora R; Ley M; Molins A; Toledo M; Sansa G; Bertol V; Becerra JL; Carreño M; Mauri JÁ
Epilepsy Behav; 2018 Feb; 79():87-92. PubMed ID: 29253680
[TBL] [Abstract][Full Text] [Related]
19. Cognition in school-aged children with "active" epilepsy: A population-based study.
Reilly C; Atkinson P; Das KB; Chin RF; Aylett SE; Burch V; Gillberg C; Scott RC; Neville BG
J Clin Exp Neuropsychol; 2015; 37(4):429-38. PubMed ID: 25921696
[TBL] [Abstract][Full Text] [Related]
20. Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments.
Luoni C; Bisulli F; Canevini MP; De Sarro G; Fattore C; Galimberti CA; Gatti G; La Neve A; Muscas G; Specchio LM; Striano S; Perucca E;
Epilepsia; 2011 Dec; 52(12):2181-91. PubMed ID: 22136077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
